Cephaeline

Cephaeline

SCHEMBL29380707

CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(O)c(OC)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 7/20 1.00
EPAS1 Q99814 3/20 1.00
SMN1; SMN2 Q16637 5/20 0.96
LMNA P02545 4/20 0.96
CYP2D6 P10635 2/20 0.96
MEN1 O00255 6/20 0.89
KMT2A Q03164 6/20 0.89
SLC2A1 P11166 5/20 0.89
CYP3A4 P08684 3/20 0.89
MAPK1 P28482 3/20 0.89
NPC1 O15118 3/20 0.89
RAB9A P51151 3/20 0.89
MAPT P10636 2/20 0.89
STAT6 P42226 2/20 0.89
TP53 P04637 1/20 0.89
NFKB1 P19838 1/20 0.89
THPO P40225 1/20 0.89
HTT P42858 1/20 0.89
RBBP9 O75884 1/20 0.89
ABCB1 P08183 1/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cephaeline SCHEMBL13912580 1.00 HIF1A (1.00) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Cephaeline SCHEMBL181711 1.00 HIF1A (1.00) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Cephaeline SCHEMBL2518794 0.99 HIF1A (0.98) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Emetine SCHEMBL11052542 0.99 HIF1A (0.98) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Cephaeline SCHEMBL31256787 0.99 HIF1A (0.98) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Cephaeline SCHEMBL19742946 0.99 HIF1A (0.98) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Cephaeline SCHEMBL2381570 0.98 HIF1A (1.00) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Cephaeline SCHEMBL20873862 0.97 HIF1A (0.93) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Emetine SCHEMBL24499457 0.94 HIF1A (1.00) HIF1AEPAS1SMN1; SMN2LMNACYP2D6
Emetine SCHEMBL14029342 0.94 HIF1A (1.00) HIF1AEPAS1SMN1; SMN2LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118252084-A Method for forcing culture of peony potted flowers 江苏农林职业技术学院 2024-06-28 CN claimed
WO-2023132531-A1 LITHIUM SECONDARY BATTERY ELECTRODE AND MANUFACTURING METHOD THEREFOR 주식회사 엘지에너지솔루션 2023-07-13 WO claimed
CN-116409916-A Glass product processing method and glass ceramic mold 重庆鑫景特种玻璃有限公司 2023-07-11 CN claimed
CN-111592226-B Preparation method of high borosilicate glass, high borosilicate glass and application thereof 佛山市顺德区美的电热电器制造有限公司 2022-12-27 CN claimed
CN-113045341-B Method for preparing alkali-free silicon fertilizer from silicon-containing acid treatment liquid and alkali-free silicon fertilizer 国家能源投资集团有限责任公司 2026-05-22 CN disclosed
WO-2026106249-A1 COATING APPARATUS 주식회사 엘지에너지솔루션 2026-05-21 WO disclosed
WO-2026101345-A1 COATING APPARATUS 주식회사 엘지에너지솔루션 2026-05-15 WO disclosed
EP-3641941-B1 AN INTEGRATED SEPARATOR SYSTEM & PROCESS FOR PRECONCENTRATION AND PRETREATMENT OF A MATERIAL UNIV QUEENSLAND (AU) 2026-05-13 EP disclosed
WO-2026086871-A1 ANTI-AGEING COMPOUNDS, USES THEREFOR, METHOD FOR IDENTIFYING, AND COMPOSITIONS CONTAINING Centre for Translational Stem Cell Biology Limited (CN) 2026-04-30 WO disclosed
WO-2026089382-A1 COATING APPARATUS 주식회사 엘지에너지솔루션 2026-04-30 WO disclosed
US-20260083724-A1 COMPOUNDS TARGETING PAX3::FOXO1 FUSION PROTEIN GEORGETOWN UNIVERSITY (US) 2026-03-26 US disclosed
US-20260002225-A1 SYSTEM FOR PROCESSING RED MUD AND METHOD OF PROCESSING RED MUD RED MUD ENTPR LLC (US) 2026-01-01 US disclosed
CN-114232067-B Preparation method of high-scandium, high-zirconium and high-water content perovskite single crystal under high temperature and high pressure 中国科学院地球化学研究所 2022-09-09 CN disclosed
CN-115038451-A Multimodal compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-09 CN disclosed
CN-115003279-A Prodrug compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-02 CN disclosed
CN-112851316-B Light-transmitting brick and preparation method thereof 清远市简一陶瓷有限公司 2022-09-02 CN disclosed
CN-110214055-B Macroporous oxygen-carrier solids with refractory feldspar/feldspar-like, method for the production thereof and use thereof in a chemical chain redox process IFP新能源公司 2022-07-12 CN disclosed
CN-114232067-A Preparation method of high-scandium, high-zirconium and high-water content perovskite single crystal under high temperature and high pressure 中国科学院地球化学研究所 2022-03-25 CN disclosed
CN-111072393-B Environment-friendly dry type impermeable material suitable for aluminum electrolytic cell 内蒙古风光源节能环保科技有限公司 2022-02-15 CN disclosed
CN-114026175-A Thermoplastic resin composition 帝人株式会社 2022-02-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002225-A1 SYSTEM FOR PROCESSING RED MUD AND METHOD OF PROCESSING RED MUD RBM22, AS3MT, STAU1 HIF1A 1995/4885EPAS1 4591/4885SMN1; SMN2 133/4885
US-20260083724-A1 COMPOUNDS TARGETING PAX3::FOXO1 FUSION PROTEIN PAX3, FOXO1, PAXBP1 HIF1A 3010/4885EPAS1 2121/4885SMN1; SMN2 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.